Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
78.4M
-
Number of holders
-
137
-
Total 13F shares, excl. options
-
56.8M
-
Shares change
-
-2.09M
-
Total reported value, excl. options
-
$1.99B
-
Value change
-
-$21.7M
-
Put/Call ratio
-
0.91
-
Number of buys
-
94
-
Number of sells
-
-45
-
Price
-
$35.06
Significant Holders of Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) as of Q3 2021
166 filings reported holding AVIR - Atea Pharmaceuticals, Inc. - COMMON STOCK as of Q3 2021.
Atea Pharmaceuticals, Inc. - COMMON STOCK (AVIR) has 137 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 56.8M shares
of 78.4M outstanding shares and own 72.49% of the company stock.
Largest 10 shareholders include FMR LLC (12.4M shares), RA CAPITAL MANAGEMENT, L.P. (5.43M shares), VANGUARD GROUP INC (5.18M shares), Cormorant Asset Management, LP (4.93M shares), BlackRock Inc. (4.14M shares), Bain Capital Life Sciences Investors, LLC (3.7M shares), PERCEPTIVE ADVISORS LLC (2.26M shares), VIKING GLOBAL INVESTORS LP (1.66M shares), AJU IB Investment Co., Ltd. (1.64M shares), and PRICE T ROWE ASSOCIATES INC /MD/ (1.5M shares).
This table shows the top 137 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.